Is There Any Role of DCB for the Treatment of De Novo Lesions? - Juan Granada, MD

↳ This is a section part of Moment: CRT 2016 Technology & Innovation - DCB Technology Symposium - Coronary

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$3.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

Is There Any Role of DCB for the Treatment of De Novo Lesions? presented by Juan Granada, MD at CRT 2016

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$3.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

  • Interventional Cardiologists
  • Interventional Fellows

Session Name: DCB Technology Symposium - Coronary

Track: Technology & Innovation

Learning Objectives

  • Update in advances with bioresorbable & DCB technologies in interventional procedures

Other Components in this Moment

Overview
DCB for In-stent Restenosis: Is It Superior to DES? - Robert Byrne, MB BCh, PhD
Is There Any Role of DCB for the Treatment of De Novo Lesions? - Juan Granada, MD
DCB as Adjunct Therapy to DES and BRS - Azeem Latib, MD
DCB for Coronary Intervention: State of the Field and Where are we Going From Here? - Bruno Scheller, MD
Loading Simple Education